持续妊娠中冻胚与鲜胚移植的围产期并发症:一项在假想试验框架下开展的队列研究
该前瞻性队列研究于2017年11月至2021年8月在中国17个省份50个中心纳入5,118例体外受精/卵胞浆内单精子注射妊娠妇女,按1:1分配分析2,856例,比较冻胚与鲜胚移植的围产期结局。冻胚组围产期并发症发生率5.0%(72/1,428)与鲜胚组4.6%(66/1,428)相似,风险比1.09(95%CI 0.79–1.51);冻胚移植与妊娠期高血压风险升高相关(RR 2.18,95%CI 1.10–4.62)。作者认为两种策略围产期并发症风险相似,冻胚策略妊娠期高血压风险似乎更高,决策时应更谨慎权衡获益与潜在风险。
要点
- 冻胚与鲜胚移植围产期并发症发生率相似:5.0%(72/1,428)vs 4.6%(66/1,428),RR 1.09(95%CI 0.79–1.51)。
- 早产、小于胎龄儿、大于胎龄儿、低出生体重及巨大儿风险两组间无显著差异。
- 冻胚移植与妊娠期高血压风险升高相关:RR 2.18(95%CI 1.10–4.62)。
核心结论
- 持续妊娠中冻胚与鲜胚移植的围产期并发症风险相似,而冻胚移植策略的妊娠期高血压风险似乎更高。
- 作者认为鲜胚或冻胚移植的决策应更谨慎,仔细权衡获益与潜在风险。
研究设计与样本
- 前瞻性队列研究,在假想随机对照试验框架下开展以提高观察性数据证据的效力。
- 2017年11月至2021年8月从中国17个省份50个研究中心于孕早期招募5,118例经体外受精/卵胞浆内单精子注射妊娠的妇女。
- 暴露为冻胚移植与鲜胚移植,最终2,856例孕妇纳入分析,分配比1:1。
- 主要结局为围产期并发症,定义为围产期死亡或出生缺陷的任何发生;次要结局包括早产、小于胎龄儿、大于胎龄儿、低出生体重和巨大儿;安全性结局为流产、妊娠期高血压、妊娠期糖尿病和妊娠期甲状腺功能异常。
主要发现
- 冻胚移植组围产期并发症发生率为5.0%(72/1,428),鲜胚移植组为4.6%(66/1,428),风险比1.09(95%CI 0.79–1.51)。
- 两组间早产、小于胎龄儿、大于胎龄儿、低出生体重和巨大儿的风险无显著差异。
- 与鲜胚移植相比,冻胚移植与妊娠期高血压风险升高相关:风险比2.18(95%CI 1.10–4.62)。
临床怎么用
- 作者认为鲜胚或冻胚移植的决策应更谨慎,仔细考虑获益与潜在风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the perinatal outcomes between fresh and frozen embryo transfer strategies among ongoing pregnancies conceived by in vitro fertilization/intracytoplasmic sperm injection. DESIGN: A prospective cohort study. The study was conducted within the framework of a hypothetical randomized controlled trial to enhance the validity of the evidence obtained from observational data. SUBJECTS: From November 2017 to August 2021, 5,118 pregnant women who conceived by in vitro fertilization/intracytoplasmic sperm injection were recruited from 50 study sites in 17 provinces of China during their first trimester. EXPOSURE: Frozen vs. fresh embryo transfer. MAIN OUTCOME MEASURES: The primary outcome was perinatal complications, defined as any occurrence of perinatal death or birth defects. The secondary outcomes included preterm birth, small for gestational age, large for gestational age, low birth weight, and macrosomia. The safety outcomes were abortion, pregnancy-induced hypertension, gestational diabetes mellitus, and gestational thyroid dysfunction. RESULTS: A total of 2,856 pregnant women were included in the analysis, with the allocation ratio of 1:1. The perinatal complication rate of the frozen embryo transfer group (5.0%, 72/1,428) was similar to that of the fresh embryo transfer group (4.6%, 66/1,428), with the risk ratio of 1.09 (95% confidence interval, 0.79 to 1.51). Moreover, there was no significant difference in the risks of preterm birth, small for gestational age, large for gestational age, low birth weight, and macrosomia between the two groups. However, compared with fresh embryo transfer, frozen embryo transfer was associated with an increased risk of pregnancy-induced hypertension (risk ratio, 2.18; 95% confidence interval, 1.10 to 4.62). CONCLUSION: The risk of perinatal complications was similar between fresh and frozen embryo transfer strategies, whereas the risk of pregnancy-induced hypertension seemed to be higher for the frozen embryo transfer strategy among ongoing pregnancies. Therefore, the decision regarding fresh or frozen embryo transfer should be made with more caution, with careful consideration of the benefits and potential risks.
引用
- Yan R, Liu X, Gao S, et al. Perinatal complications of frozen vs. fresh embryo transfer among ongoing pregnancies: a cohort study conducted within the framework of a hypothetical trial. Fertil Steril. 2025. PMID: 40865754. doi:10.1016/j.fertnstert.2025.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。